Zydus Lifesciences' Rs 600 crore buyback offer to open on February 29
The share repurchase programme will close on March 6, 2024, the drug firm said in a regulatory filing.
)
Shares of the company were trading 0.38 per cent up at Rs 946.15 apiece on the BSE.
Zydus Lifesciences on Tuesday said its offer to buy back 59.7 lakh shares at Rs 1,005 apiece, aggregating to Rs 600 crore, will open on February 29.
The share repurchase programme will close on March 6, 2024, the drug firm said in a regulatory filing.
The company proposed to buy back up to 59,70,149 shares at Rs 1,005 apiece for an aggregate consideration not exceeding Rs 600 crore, it stated.
Shares of the company were trading 0.38 per cent up at Rs 946.15 apiece on the BSE.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
Written By: PTI
Updated: Tue, Feb 27, 2024
01:42 PM IST
01:42 PM IST
New Delhi, PTI
Zydus Lifesciences gets USFDA nod to produce prostrate cancer drug